会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • Diaryl ether cyclic ethers
    • 二芳基醚环醚
    • EP0409412A3
    • 1991-07-24
    • EP90306763.5
    • 1990-06-20
    • IMPERIAL CHEMICAL INDUSTRIES PLCICI PHARMA
    • Edwards, Philip NeilBird, Thomad Geoffrey Colerick
    • C07D317/18C07D317/22A61K31/335
    • C07D317/22
    • The invention concerns a diaryl ether cyclic ether of the formula I, or a pharmaceutically-acceptable salt thereof,
      wherein Ar¹ is optionally substituted phenyl or naphthyl;
      X¹ is oxy, thio, sulphinyl or sulphonyl;
      Ar² is optionally substituted phenylene, or a 6-membered heterocyclene moiety containing up to three nitrogen atoms;
      R¹ and R² together form a group of the formula -A²-X²-A³- wherein each of A² and A³ is (1-4C)alkylene and X² is oxy, thio, sulphinyl, sulphonyl or imino; and
      R³ is (1-6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl and substituted (1-4C)alkyl. The invention also concerns processes for the manufacture of a diaryl ether cyclic ether of the formula I, or a pharmaceutically-acceptable salt thereof, and pharmaceutical compositions containing said cyclic ether. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.
    • 本发明涉及式I的二芳基醚环醚或其药学上可接受的盐,其中Ar 1是任选取代的苯基或萘基; X 1是氧,硫,亚磺酰基或磺酰基; Ar 2是任选取代的亚苯基或含有至多三个氮原子的6元杂环部分; R 1和R 2一起形成式-A 2 -X 2 -A 3 - 的基团,其中A 2和A 3各自是(1-4C)亚烷基,X 2是氧,硫,亚磺酰基,磺酰基或亚氨基; (1-6C)烷基,(2-6C)链烯基,(2-6C)炔基和取代的(1-4C)烷基。 本发明还涉及制备式I的二芳基醚环状醚或其药学上可接受的盐的方法,以及含有所述环状醚的药物组合物。 本发明的化合物是5-脂氧合酶的抑制剂。
    • 4. 发明公开
    • Diaryl ether cycloalkanes
    • 二芳基醚环烷烃
    • EP0409414A1
    • 1991-01-23
    • EP90306766.8
    • 1990-06-20
    • IMPERIAL CHEMICAL INDUSTRIES PLCICI PHARMA
    • Edwards, Philip NeilBird, Thomas Geoffrey Colerick
    • C07C323/18A61K31/10
    • C07C323/18
    • The invention concerns a diaryl ether cycloalkane of the formula I, or a pharmaceutically-acceptable salt thereof,
      wherein Ar¹ is optionally substituted phenyl or naphthyl;
      X¹ is oxy, thio, sulphinyl or sulphonyl;
      Ar² is optionally substituted phenylene, or a 6-membered heterocyclene moiety containing up to three nitrogen atoms;
      R¹ is (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, cyano-(1-4C)alkyl or (2-4C)alkanoyl, or optionally substituted benzoyl; and
      R² and R³ together form a (3-6C)alkylene group which defines an optionally substituted ring having 4 to 7 ring atoms.
      The invention also concerns processes for the manufacture of a diaryl ether cycloalkane of the formula I, or a pharmaceutically-acceptable salt thereof, and pharmaceutical compositions containing said cycloalkane. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.
    • 本发明涉及式I的二芳基醚环烷烃或其药学上可接受的盐,其中Ar 1是任选取代的苯基或萘基; X 1是氧,硫,亚磺酰基或磺酰基; Ar 2是任选取代的亚苯基或含有至多三个氮原子的6元杂环部分; (1-6C)烷基,(3-6C)烯基,(3-6C)炔基,氰基 - (1-4C)烷基或(2-4C)烷酰基或任选取代的苯甲酰基; 并且R 2和R 3一起形成一个(3-6C)亚烷基,它定义了一个任选取代的具有4至7个环原子的环。 本发明还涉及制备式I的二芳基醚环烷烃或其药学上可接受的盐的方法和含有所述环烷烃的药物组合物。 本发明的化合物是5-脂氧合酶的抑制剂。
    • 5. 发明公开
    • Diaryl ether heterocycles
    • Diaryläther-Heterozyklen。
    • EP0409413A2
    • 1991-01-23
    • EP90306765.0
    • 1990-06-20
    • IMPERIAL CHEMICAL INDUSTRIES PLCICI PHARMA
    • Edwards, Philip NeilBird, Thomas Geoffrey Colerick
    • C07D309/10C07D409/12A61K31/35
    • C07D409/12C07D307/20C07D309/10
    • The invention concerns a diaryl ether heterocycle of the formula I, or a pharmaceutically-acceptable salt thereof,
      wherein Ar¹ is optionally substituted phenyl or naphthyl;
      X¹ is oxy, thio, sulphinyl or sulphonyl;
      Ar² is optionally substituted phenylene, or a 6-membered heterocyclene moiety containing up to three nitrogen atoms;
      R¹ is (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, cyano-(1-4C)alkyl or (2-4C)alkanoyl, or optionally substituted benzoyl; and
      R² and R³ together form a group of the formula -A²-X²-A³- wherein each of A² and A³ is (1-4C)alkylene and X² is oxy, thio, sulphinyl, sulphonyl or imino.
      The invention also concerns processes for the manufacture of a diaryl ether heterocycle of the formula I, or a pharmaceutically-acceptable salt thereof, and pharmaceutical compositions containing said heterocycle. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.
    • 本发明涉及式I的二芳基醚杂环或其药学上可接受的盐,其中Ar 1是任选取代的苯基或萘基; X 1是氧基,硫基,亚磺酰基或磺酰基; Ar 2是任选取代的亚苯基,或含有至多三个氮原子的6-元杂环烯部分; (1-6C)烷基,(3-6C)烯基,(3-6C)炔基,氰基 - (1-4C)烷基或(2-4C)烷酰基或任选取代的苯甲酰基; 并且R 2和R 3一起形成式-A 2 -X 2 -A 3 - 的基团,其中A 2和A 3各自为(1-4C )亚烷基,X 2是氧基,硫基,亚磺酰基,磺酰基或亚氨基。 本发明还涉及制备式I的二芳基醚杂环或其药学上可接受的盐以及含有所述杂环的药物组合物的方法。 本发明的化合物是5-脂氧合酶的抑制剂。
    • 7. 发明公开
    • Phenol derivatives
    • 苯酚衍生物
    • EP0160508A3
    • 1986-10-08
    • EP85302882
    • 1985-04-24
    • IMPERIAL CHEMICAL INDUSTRIES PLC
    • Edwards, Philip NeilTait, Brian Steele
    • C07C103/34C07C125/065C07C147/14C07C149/16C07C149/247C07C149/273C07D207/16A61K31/16A61K31/215A61K31/10
    • C07D207/16C07C271/22C07C317/00C07C323/00
    • Mono- or bis-complex esters or ethers of a phenol derivative of the formula
      wherein NU is a defined mono- or bis-phenolic nucleus including a hydroxyphenyl-hydroxynaphthyl;
      hydroxyphenyl-hydroxyindanyl, hydroxyphenyl-hydroxy--benzothienyl or di-hydrdxyphenyl-ethylene or vinylene nucleus; wherein A is alkylene, alkenylene or alkynylene which may be interrupted by phenylene or other linkages, wherein R'is hydrogen, or alkyl, alkenyl, cycloalkyl, halogenoalkyl, aryl or arylalkyl, or R' is joined to R 2 , and wherein X is -CONR 2 -, -CSNR 2 -,-NR 12 CO-, -NR 12 CS-, -NR 12 CONR 2 -,
      -SO 2 NR 2 - or -CO-, or, when R 1 is not hydrogen, is -NR 12 COO-, -S-, -SO- or -S0 2 -, wherein R 2 is hydrogen or alkyl, or R 1 and R 2 together form alkylene; wherein R 12 is hydrogen or alkyl, and wherein R 22 is hydrogen, cyano or nitro; or a salt thereof when appropriate. The compounds possess antioestrogenic activity and may be used for the treatment of hormone-dependent breast tumours or of anovulatory infertility.
    • 下式的酚衍生物的单或双配位酯或醚,其中NU是定义的单酚或双酚核,包括羟苯基 - 羟基萘基; 羟基苯基 - 羟基茚基,羟基苯基 - 羟基 - 苯并噻吩基或二 - 羟基苯基 - 乙烯或亚乙烯基核; 其中A为亚烷基,亚烯基或亚炔基,其可被亚苯基或其它键中断,其中R'为氢或烷基,烯基,环烷基,卤代烷基,芳基或芳基烷基,或R'与R2连接,且其中X为 - CONR 2 - , - CSNR 2 - , - NR 12 CO - , - NR 12 CS-,-NR 12 CONR 2 - , - SO 2 NR 2 - 或-CO-,或者当R 1不为氢时为-NR 12 COO - - ,其中R 2是氢或烷基,或者R 1和R 2一起形成亚烷基; 其中R12是氢或烷基,并且其中R22是氢,氰基或硝基; 或适当的盐。 该化合物具有抗雌激素活性,可用于治疗激素依赖性乳腺肿瘤或无排卵性不育症。